NCT06330766

Brief Summary

In Odense University Hospital preoperative dental screening (PDS) protocol for patients treated with Transcatheter Aortic Valve Implantation (TAVI) was changed from mandatory to targeted PDS to between June 2023 to october 2023. The investigators will therefore compare the risk of IE before june 2023 and after october 2023.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
4.1 years until next milestone

First Submitted

Initial submission to the registry

February 19, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 26, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

March 26, 2024

Status Verified

March 1, 2024

Enrollment Period

6 years

First QC Date

February 19, 2024

Last Update Submit

March 19, 2024

Conditions

Keywords

Transcatheter aortic valve implantationTAVIPreoperative dental screeningInfectious endocarditis

Outcome Measures

Primary Outcomes (1)

  • Number of Participants with Infectious Endocarditis

    Infectious endocarditis diagnosed by healthcare professionals

    Through study completion, an average of 1 year

Secondary Outcomes (6)

  • Number of Participants undergoing Oral surgical procedure at dental screening

    Through study completion, an average of 1 year

  • Number of Participants undergoing Tooth extraction at dental screening

    Through study completion, an average of 1 year

  • The different Bacteria types causing the infectious endocarditis assessed by blood culture

    Through study completion, an average of 1 year

  • Number patients with Bacteremia assessed by positive blood culture

    Through study completion, an average of 1 year

  • Number of Participants with IE caused by bacteria from oral foci

    Through study completion, an average of 1 year

  • +1 more secondary outcomes

Study Arms (2)

No preoperative dental screening

No preoperative dental screening in patients undergoing TAVI

Procedure: No preoperative dental screening

Mandatory preoperative dental screening

Mandatory preoperative dental screening in patients undergoing TAVI

Interventions

Discontinuance of mandatory preoperative dental screening prior TAVI which also can include oral surgery.

No preoperative dental screening

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients undergoing TAVI from Oktober 2023 to January 2026 from Odense University Hospital and Aalborg University Hospital compared with same type of patients from the same centers from the period January 2020 to June 2023.

You may qualify if:

  • Patients undergoing TAVI

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Odense University Hospital, Cardiology Department

Odense, 5000, Denmark

RECRUITING

Related Publications (11)

  • Que YA, Moreillon P. Infective endocarditis. Nat Rev Cardiol. 2011 Jun;8(6):322-36. doi: 10.1038/nrcardio.2011.43. Epub 2011 Apr 12.

    PMID: 21487430BACKGROUND
  • Piper C, Korfer R, Horstkotte D. Prosthetic valve endocarditis. Heart. 2001 May;85(5):590-3. doi: 10.1136/heart.85.5.590. No abstract available.

    PMID: 11303018BACKGROUND
  • Ostergaard L, Valeur N, Ihlemann N, Smerup MH, Bundgaard H, Gislason G, Torp-Pedersen C, Bruun NE, Kober L, Fosbol EL. Incidence and factors associated with infective endocarditis in patients undergoing left-sided heart valve replacement. Eur Heart J. 2018 Jul 21;39(28):2668-2675. doi: 10.1093/eurheartj/ehy153.

    PMID: 29584858BACKGROUND
  • Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg JM, Baltimore RS, Fink AM, O'Gara P, Taubert KA; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015 Oct 13;132(15):1435-86. doi: 10.1161/CIR.0000000000000296. Epub 2015 Sep 15.

    PMID: 26373316BACKGROUND
  • Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H, Caselli S, Doenst T, Ederhy S, Erba PA, Foldager D, Fosbol EL, Kovac J, Mestres CA, Miller OI, Miro JM, Pazdernik M, Pizzi MN, Quintana E, Rasmussen TB, Ristic AD, Rodes-Cabau J, Sionis A, Zuhlke LJ, Borger MA; ESC Scientific Document Group. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J. 2023 Oct 14;44(39):3948-4042. doi: 10.1093/eurheartj/ehad193. No abstract available.

    PMID: 37622656BACKGROUND
  • Mentias A, Girotra S, Desai MY, Horwitz PA, Rossen JD, Saad M, Panaich S, Kapadia S, Sarrazin MV. Incidence, Predictors, and Outcomes of Endocarditis After Transcatheter Aortic Valve Replacement in the United States. JACC Cardiovasc Interv. 2020 Sep 14;13(17):1973-1982. doi: 10.1016/j.jcin.2020.05.012.

    PMID: 32912457BACKGROUND
  • Butt JH, Ihlemann N, De Backer O, Sondergaard L, Havers-Borgersen E, Gislason GH, Torp-Pedersen C, Kober L, Fosbol EL. Long-Term Risk of Infective Endocarditis After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2019 Apr 9;73(13):1646-1655. doi: 10.1016/j.jacc.2018.12.078.

    PMID: 30947917BACKGROUND
  • Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O'Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Feb 2;143(5):e72-e227. doi: 10.1161/CIR.0000000000000923. Epub 2020 Dec 17. No abstract available.

    PMID: 33332150BACKGROUND
  • Buckley AJ, Hensey M, O'Connor S, Maree A. Dental screening prior to transcatheter versus surgical aortic valve replacement: International Survey of Current Practices. Catheter Cardiovasc Interv. 2023 Jul;102(1):176-177. doi: 10.1002/ccd.30675. Epub 2023 May 7. No abstract available.

    PMID: 37149755BACKGROUND
  • Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, Juni P, Pierard L, Prendergast BD, Sadaba JR, Tribouilloy C, Wojakowski W; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395. No abstract available.

    PMID: 34453165BACKGROUND
  • Krasniqi L, Schodt Riber LP, Nissen H, Terkelsen CJ, Andersen NH, Freeman P, Povlsen JA, Gerke O, Clavel MA, Dahl JS. Impact of mandatory preoperative dental screening on post-procedural risk of infective endocarditis in patients undergoing transcatheter aortic valve implantation: a nationwide retrospective observational study. Lancet Reg Health Eur. 2023 Nov 22;36:100789. doi: 10.1016/j.lanepe.2023.100789. eCollection 2024 Jan.

    PMID: 38188272BACKGROUND

MeSH Terms

Conditions

EndocarditisEndocarditis, Subacute Bacterial

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesEndocarditis, BacterialBacterial InfectionsBacterial Infections and MycosesInfectionsStreptococcal InfectionsGram-Positive Bacterial InfectionsCardiovascular Infections

Study Officials

  • Jordi S Dahl, MD,PhD,DMSc

    Odense University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jordi S Dahl, MD,PhD,DMSc

CONTACT

Lytfi Krasniqi, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Chief physician in charge of cardiology imaging

Study Record Dates

First Submitted

February 19, 2024

First Posted

March 26, 2024

Study Start

January 1, 2020

Primary Completion

January 1, 2026

Study Completion

January 1, 2026

Last Updated

March 26, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share

Data from this study, encompassing both individual participant information and a comprehensive data dictionary that defines each field, will be accessible to interested parties. Specifically, we'll be sharing deidentified participant data paired with the mentioned data dictionary. Study protocol and statistical analysis plan will be provided. Prospective researchers can anticipate data availability concurrent with the publication of our findings. To gain access, reach out to Lytfi.Krasniqi@rsyd.dk. Data will be shared with researchers whose proposed use has received approval. Access will be granted primarily for the replication of the results presented in our study.

Shared Documents
STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
Time Frame
To be announced
Access Criteria
A signed data access agreement, compliant with regional legislation and data authority requirements, must be obtained prior to data release.

Locations